APN:JSE
アスペンファーマ
ZAC 13,900.00
arrow_downward
-1.16%(-163.00) 1 日
4月30日, 17:02:52 GMT+2 · ZAC
search
すべての記号
1 日
5 日
1 か月
6 か月
年初来
1 年
5 年
最大
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoAPN の上位の分析情報を生成しています...
始値
ZAC 13,941.00
高値
ZAC 14,200.00
安値
ZAC 13,870.00
時価総額
620.29億
平均出来高
111.66万
取引量
183.71万
配当
1.52%
四半期配当
ZAC 52.75
配当落ち日
2025/10/01
52 週高値
ZAC 14,458.00
52 週安値
ZAC 9,070.00
EPS
-ZAC 4.51
発行済株式数
4.46億
従業員数
9343
ニュース記事
ウェブの情報から
プロフィール
Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange in 1998, and purchased South African Druggists in 1999 before expanding into international markets. Currently the largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016 Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for 5 years in the European Union. Wikipedia
アスペンファーマ について